(0.01%) 5 469.76 points
(0.14%) 39 169 points
(0.26%) 17 764 points
(0.00%) $80.83
(-5.04%) $2.62
(-0.88%) $2 310.40
(-0.22%) $28.81
(3.22%) $1 018.20
(0.33%) $0.936
(0.73%) $10.68
(0.50%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally...
Stats | |
---|---|
Dagens volum | 1.39M |
Gjennomsnittsvolum | 1.98M |
Markedsverdi | 907.24M |
EPS | $-0.0913 ( Q1 | 2024-05-09 ) |
Neste inntjeningsdato | ( $0 ) 2024-08-05 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-6.90 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00600 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-28 | Gtcr Investment Xi Llc | Sell | 8 409 946 | Class B common stock |
2024-05-28 | Gtcr Investment Xi Llc | Sell | 8 409 946 | Common Units |
2024-05-28 | Gtcr Investment Xi Llc | Buy | 8 409 946 | Class A common stock |
2024-05-28 | Gtcr Investment Xi Llc | Sell | 9 940 974 | Class A common stock |
2024-05-23 | Mihas Constantine S | Buy | 20 645 | Class A Common Stock |
INSIDER POWER |
---|
-42.48 |
Last 97 transactions |
Buy: 13 786 648 | Sell: 31 686 588 |
Volum Korrelasjon
Maravai LifeSciences Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
GRMN | 0.911 |
DINT | 0.905 |
ZBRA | 0.905 |
AQWA | 0.899 |
ULBI | 0.886 |
MMLP | 0.88 |
IESC | 0.878 |
AAXJ | 0.878 |
CTRE | 0.877 |
AIA | 0.877 |
10 Mest negative korrelasjoner | |
---|---|
ATOM | -0.875 |
AKAM | -0.872 |
PEV | -0.867 |
FRSH | -0.855 |
SYPR | -0.853 |
OTEX | -0.842 |
VRSN | -0.84 |
IONS | -0.835 |
ENSC | -0.828 |
CVRX | -0.825 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Maravai LifeSciences Korrelasjon - Valuta/Råvare
Maravai LifeSciences Økonomi
Annual | 2023 |
Omsetning: | $288.95M |
Bruttogevinst: | $137.60M (47.62 %) |
EPS: | $-0.900 |
FY | 2023 |
Omsetning: | $288.95M |
Bruttogevinst: | $137.60M (47.62 %) |
EPS: | $-0.900 |
FY | 2022 |
Omsetning: | $883.00M |
Bruttogevinst: | $714.04M (80.87 %) |
EPS: | $3.73 |
FY | 2021 |
Omsetning: | $799.24M |
Bruttogevinst: | $658.68M (82.41 %) |
EPS: | $1.590 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Maravai LifeSciences
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as plasmid DNA and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.